Table 6 Adverse events

Number randomized

55

50

Participants who had any adverse event (AE), n (%)^a

33 (60)

27 (54.0)

Participants who had any severe adverse event (SAE), n (%)^a

0

0

Participants who had any grade 3 or 4 adverse events, n (%)^b

2 (6.1)

3 (11.1)

Number of grade 3 or 4 AEs

2

3

 Grade 3 or 4 adverse events listing, number

  Elevated QTc (> 450 males, > 470 females)

1

3

  Painful eye after HCQ dosages

1

0

Grade 3 or 4 relationship with study drug, number

 Definite^c

1

N/A

 Probable

0

N/A

 Possible

0

N/A

 Unlikely

0

N/A

 Unrelated

1

N/A